Exact Mass: 582.098

Exact Mass Matches: 582.098

Found 74 metabolites which its exact mass value is equals to given mass value 582.098, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Telomestatin

4,8-dimethyl-3,7,11,15,19,23,27-heptaoxa-31-thia-33,34,35,36,37,38,39,40-octazanonacyclo[28.2.1.12,5.16,9.110,13.114,17.118,21.122,25.126,29]tetraconta-2(40),4,6(39),8,10(38),12,14(37),16,18(36),20,22(35),24,26(34),28,30(33)-pentadecaene

C26H14N8O7S (582.0706)


Telomestatin is a naturally occurring organic compound classified as a cyclic phenolphthioceramide derivative. It is isolated from the fermentation broth of microorganisms and is known for its antitumor properties. The name "telomestatin" reflects its primary mode of action, which is the inhibition of telomerase, an enzyme crucial for the maintenance of chromosome stability and cell proliferation, particularly in cancer cells where telomerase activity is often elevated. Telomerase is responsible for adding repetitive DNA sequences called telomeres to the ends of chromosomes, which prevents the loss of genetic material during DNA replication and cell division. By inhibiting telomerase, telomestatin interferes with the ability of cancer cells to divide and proliferate, making it a potential candidate for antitumor therapy. The compound's unique chemical structure allows it to bind specifically to the telomerase RNA component, thereby blocking the enzyme's activity. The discovery and study of telomestatin have contributed to the understanding of telomerase biology and the development of potential therapeutic strategies for cancer treatment.

   

5'-Methoxybilobetin

8-[5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2,3-dimethoxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one

C32H22O11 (582.1162)


5-Methoxybilobetin is found in fats and oils. 5-Methoxybilobetin is isolated from Ginkgo biloba (ginkgo). Isolated from Ginkgo biloba (ginkgo). 5-Methoxybilobetin is found in ginkgo nuts and fats and oils.

   

[2,6-dihydroxy-4-(7-methyl-11-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl)phenoxy]dihydroxyoxo-λ⁶-sulfanylium

[2,6-Dihydroxy-4-(7-methyl-11-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,8-dioxatricyclo[7.3.1.0,(1)(3)]trideca-1(12),3,5(13),6,9-pentaen-3-yl)phenoxy]dihydroxyoxo-lambda-sulfanylium

C24H22O15S (582.0679)


[2,6-dihydroxy-4-(7-methyl-11-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl)phenoxy]dihydroxyoxo-λ⁶-sulfanylium is classified as a member of the flavonoid-3-o-glycosides. Flavonoid-3-O-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position. [2,6-dihydroxy-4-(7-methyl-11-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl)phenoxy]dihydroxyoxo-λ⁶-sulfanylium is considered to be a practically insoluble (in water) and a moderately acidic compound. [2,6-dihydroxy-4-(7-methyl-11-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-3-yl)phenoxy]dihydroxyoxo-λ⁶-sulfanylium can be found in humans.

   

Ivosidenib

2-(2-chlorophenyl)-2-{1-[1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl]-N-(5-fluoropyridin-3-yl)formamido}-N-(3,3-difluorocyclobutyl)acetamide

C28H22ClF3N6O3 (582.1394)


   

Bulbineloneside D

Bulbineloneside D

C29H26O13 (582.1373)


   

2'-O-Vanilloylvitexin

2- (4-Hydroxyphenyl) -5,7-dihydroxy-8- (2-O-vanilloyl-beta-D-glucopyranosyl) -4H-1-benzopyran-4-one

C29H26O13 (582.1373)


   

Perfoliatumin B

5,7,3,4-Tetrahydroxyflavone 6-C- (6"-O-p-methoxybenzoylglucoside)

C29H26O13 (582.1373)


   

4-O-Demethylknipholone-4-beta-D-glucopyranoside

4-O-Demethylknipholone-4-beta-D-glucopyranoside

C29H26O13 (582.1373)


   

bromophycolide N

bromophycolide N

C27H36Br2O4 (582.098)


   

bromophycolide U

bromophycolide U

C27H36Br2O4 (582.098)


   

bromophycolide Q

bromophycolide Q

C27H36Br2O4 (582.098)


   

callophycoic acid C

callophycoic acid C

C27H36Br2O4 (582.098)


A dibenzooxepine diterpenoid that is hexahydrodibenzo[b,e]oxepine-2-carboxylic acid with an isolated double bond between positions 6a and 7 and is substituted by a bromo, 2-[(1S,3S,6S)-3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl]ethyl and a methyl group at positions 9, 10 and 10 respectively (the 9S,10S,10aR stereoisomer). It is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.

   

bromophycolide S

bromophycolide S

C27H36Br2O4 (582.098)


   

EGCG-ph|epigallocatechin-3-O-gallat-(4beta-2)-phloroglucinol|epigallocatechin-3-O-gallate-(4beta->2)-ph

EGCG-ph|epigallocatechin-3-O-gallat-(4beta-2)-phloroglucinol|epigallocatechin-3-O-gallate-(4beta->2)-ph

C28H22O14 (582.101)


   

bromophycolide E

bromophycolide E

C27H36Br2O4 (582.098)


   

quercetin 3-O-(6-O-phenylacetyl)-beta-D-glucopyranoside|thotneoside B

quercetin 3-O-(6-O-phenylacetyl)-beta-D-glucopyranoside|thotneoside B

C29H26O13 (582.1373)


   

Acethyltectograndone

Acethyltectograndone

C32H22O11 (582.1162)


   

callophycoic acid D

callophycoic acid D

C27H36Br2O4 (582.098)


A dibenzooxepine diterpenoid that is hexahydrodibenzo[b,e]oxepine-2-carboxylic acid with an isolated double bond between positions 6 and 6a and is substituted by a bromo, 2-[(1S,3S,6S)-3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl]ethyl and a methyl group at positions 9, 10 and 10 respectively (the 9S,10S,10aR stereoisomer). An isomer of callophycoic acid C, it is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.

   

Penta-Ac-Dothistromin

Penta-Ac-Dothistromin

C28H22O14 (582.101)


   

luteolin 6,8-di-C-alpha-L-arabinopyranoside

luteolin 6,8-di-C-alpha-L-arabinopyranoside

C25H26O16 (582.1221)


   

bromophycolide P

bromophycolide P

C27H36Br2O4 (582.098)


   

M-4-demethylkhipholone-2-O-beta-D-glucopyranoside

M-4-demethylkhipholone-2-O-beta-D-glucopyranoside

C29H26O13 (582.1373)


   

2-O-Vanilloylvitexin

2-O-Vanilloylvitexin

C29H26O13 (582.1373)


   

bromophycolide M

bromophycolide M

C27H36Br2O4 (582.098)


   

5-Methoxybilobetin

8-[5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2,3-dimethoxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one

C32H22O11 (582.1162)


   

AG-120

Ivosidenib

C28H22ClF3N6O3 (582.1394)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C137826 - Isocitrate Dehydrogenase Inhibitor > C168618 - IDH1 inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors IDH1 Inhibitor 8 (91) is isocitrate dehydrogenase 1 (IDH1) inhibitor. IDH1 Inhibitor 8 can be used for the research of cancer[1]. Ivosidenib (AG-120) is an orally active inhibitor of isocitrate dehydrogenase 1 mutant (mIDH1) enzyme, it exhibits profound d-2-hydroxyglutatrate (2-HG) lowering in vivo. Ivosidenib (AG-120) has the potential for AML therapy due to its acceptable safety profile and clinical activity[1].

   
   

disodium,2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline-3,8-disulfonate,hydrate

disodium,2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline-3,8-disulfonate,hydrate

C26H20N2Na2O7S2 (582.0507)


   

2-methoxyethyl N-[5-(acetylamino)-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-methoxyphenyl]-beta-alaninate

2-methoxyethyl N-[5-(acetylamino)-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-methoxyphenyl]-beta-alaninate

C21H23BrN6O9 (582.071)


   
   

(1S)​-1-​(Diphenylphosphino)​-​2-​[(1R)​-​1-​(diphenylphosphino)​ethyl]ferrocene

(1S)​-1-​(Diphenylphosphino)​-​2-​[(1R)​-​1-​(diphenylphosphino)​ethyl]ferrocene

C36H32FeP2 (582.1329)


   
   

(2-(F-Hexyl)ethyl) dimorpholinophosphoramidate

(2-(F-Hexyl)ethyl) dimorpholinophosphoramidate

C16H20F13N2O4P (582.0953)


   

3-sinapoyloxypropylglucosinolate

3-sinapoyloxypropylglucosinolate

C21H28NO14S2- (582.0951)


   

4-O-demethylknipholone-4-O-beta-D-glucopyranoside

4-O-demethylknipholone-4-O-beta-D-glucopyranoside

C29H26O13 (582.1373)


An anthraquinone that is knipholone in which the O-methyl group is replaced by a beta-D-glucopyranosyl group. It is isolated from the roots of Bulbine frutescens and exhibits trypanocidal and antiplasmodial activities.

   

(R,S)-Ivosidenib

(R,S)-Ivosidenib

C28H22ClF3N6O3 (582.1394)


(R,S)-Ivosidenib ((R,S)-AG-120) is the less active enantiomer of Ivosidenib (AG-120)[1].

   

1-(3-acetyl-2,6-dihydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-2,6-dihydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

bromophycolide t

bromophycolide t

C27H36Br2O4 (582.098)


   

(1r,14s,15s)-14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,10-tetraene-5-carboxylic acid

(1r,14s,15s)-14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,10-tetraene-5-carboxylic acid

C27H36Br2O4 (582.098)


   

(1r,14s,15s)-14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,11-tetraene-5-carboxylic acid

(1r,14s,15s)-14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,11-tetraene-5-carboxylic acid

C27H36Br2O4 (582.098)


   

(7s,8s,11r,12s,15s)-7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,18,20-tetraen-17-one

(7s,8s,11r,12s,15s)-7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,18,20-tetraen-17-one

C27H36Br2O4 (582.098)


   

Adenosine 5'-diphosphoribose sodium salt

Adenosine 5'-diphosphoribose sodium salt

C15H23N5NaO14P2 (582.0614)


   

19,32-dihydroxy-15-methoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.1¹,⁴.1²,²⁴.1¹²,¹⁶.1¹⁸,²².0³,⁹]dotriaconta-4,7,12,14,16(31),18(30),19,21-octaene-11,27,29-trione

19,32-dihydroxy-15-methoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.1¹,⁴.1²,²⁴.1¹²,¹⁶.1¹⁸,²².0³,⁹]dotriaconta-4,7,12,14,16(31),18(30),19,21-octaene-11,27,29-trione

C27H22N2O9S2 (582.0767)


   

1-(3-acetyl-4,6-dihydroxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-4,6-dihydroxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,18,20-tetraen-17-one

7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),3,18,20-tetraen-17-one

C27H36Br2O4 (582.098)


   

(2r,3r,4s)-5,7-dihydroxy-4-(2,4,6-trihydroxyphenyl)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

(2r,3r,4s)-5,7-dihydroxy-4-(2,4,6-trihydroxyphenyl)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C28H22O14 (582.101)


   

2,2',4,4',5,5'-hexahydroxy-7-(2-hydroxypropyl)-7'-methyl-[1,1'-bianthracene]-9,9',10,10'-tetrone

2,2',4,4',5,5'-hexahydroxy-7-(2-hydroxypropyl)-7'-methyl-[1,1'-bianthracene]-9,9',10,10'-tetrone

C32H22O11 (582.1162)


   

(2s,3r,4s,5s,6s)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

(2s,3r,4s,5s,6s)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

C29H26O13 (582.1373)


   

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis[(3,4,5-trihydroxyoxan-2-yl)oxy]chromen-4-one

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis[(3,4,5-trihydroxyoxan-2-yl)oxy]chromen-4-one

C25H26O16 (582.1221)


   

14,18-dibromo-7-hydroxy-15,19,21,21-tetramethyl-11-methylidene-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24)-trien-3-one

14,18-dibromo-7-hydroxy-15,19,21,21-tetramethyl-11-methylidene-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24)-trien-3-one

C27H36Br2O4 (582.098)


   

2,2',4,8,8'-pentahydroxy-6,6'-dimethoxy-3,3'-dimethyl-[1,1'-bianthracene]-9,9',10,10'-tetrone

2,2',4,8,8'-pentahydroxy-6,6'-dimethoxy-3,3'-dimethyl-[1,1'-bianthracene]-9,9',10,10'-tetrone

C32H22O11 (582.1162)


   

14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,10-tetraene-5-carboxylic acid

14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,10-tetraene-5-carboxylic acid

C27H36Br2O4 (582.098)


   

(1s,10r,14s,15s,18r,19r)-14,18-dibromo-7-hydroxy-15,19,21,21-tetramethyl-11-methylidene-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24)-trien-3-one

(1s,10r,14s,15s,18r,19r)-14,18-dibromo-7-hydroxy-15,19,21,21-tetramethyl-11-methylidene-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24)-trien-3-one

C27H36Br2O4 (582.098)


   

5,7-dihydroxy-4-(2,4,6-trihydroxyphenyl)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

5,7-dihydroxy-4-(2,4,6-trihydroxyphenyl)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate

C28H22O14 (582.101)


   

2''-o-vanilloylvitexin

2''-o-vanilloylvitexin

C29H26O13 (582.1373)


   

(7s,8s,11s,13s,16s)-7-bromo-16-(2-bromopropan-2-yl)-22-hydroxy-8,13-dimethyl-4-methylidene-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one

(7s,8s,11s,13s,16s)-7-bromo-16-(2-bromopropan-2-yl)-22-hydroxy-8,13-dimethyl-4-methylidene-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one

C27H36Br2O4 (582.098)


   

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-2,6-dihydroxy-4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

14,18-dibromo-7-hydroxy-11,15,19,21,21-pentamethyl-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24),10-tetraen-3-one

14,18-dibromo-7-hydroxy-11,15,19,21,21-pentamethyl-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24),10-tetraen-3-one

C27H36Br2O4 (582.098)


   

2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

C29H26O13 (582.1373)


   

(2s,3r,4s,5s,6r)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

(2s,3r,4s,5s,6r)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 4-hydroxy-3-methoxybenzoate

C29H26O13 (582.1373)


   

(3r,7s,8s,11r,12s,15s)-7,11-dibromo-12,21-dihydroxy-8,12-dimethyl-4-methylidene-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),18,20-trien-17-one

(3r,7s,8s,11r,12s,15s)-7,11-dibromo-12,21-dihydroxy-8,12-dimethyl-4-methylidene-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),18,20-trien-17-one

C27H36Br2O4 (582.098)


   

7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),4,18,20-tetraen-17-one

7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),4,18,20-tetraen-17-one

C27H36Br2O4 (582.098)


   

14,18-dibromo-7-hydroxy-11,15,19,21,21-pentamethyl-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24),11-tetraen-3-one

14,18-dibromo-7-hydroxy-11,15,19,21,21-pentamethyl-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24),11-tetraen-3-one

C27H36Br2O4 (582.098)


   

(1r,3s,9s,24r,32r)-19,32-dihydroxy-15-methoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.1¹,⁴.1²,²⁴.1¹²,¹⁶.1¹⁸,²².0³,⁹]dotriaconta-4,7,12,14,16(31),18(30),19,21-octaene-11,27,29-trione

(1r,3s,9s,24r,32r)-19,32-dihydroxy-15-methoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.1¹,⁴.1²,²⁴.1¹²,¹⁶.1¹⁸,²².0³,⁹]dotriaconta-4,7,12,14,16(31),18(30),19,21-octaene-11,27,29-trione

C27H22N2O9S2 (582.0767)


   

1-(3-acetyl-4,6-dihydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

1-(3-acetyl-4,6-dihydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione

C29H26O13 (582.1373)


   

14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,11-tetraene-5-carboxylic acid

14-bromo-15-[2-(3-bromo-6-hydroxy-2,2,6-trimethylcyclohexyl)ethyl]-15-methyl-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-3,5,7,11-tetraene-5-carboxylic acid

C27H36Br2O4 (582.098)


   

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3s,4s,5r,6r)-3,4,6-trihydroxy-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}chromen-4-one

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3s,4s,5r,6r)-3,4,6-trihydroxy-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}chromen-4-one

C25H26O16 (582.1221)


   

7,11-dibromo-12,21-dihydroxy-8,12-dimethyl-4-methylidene-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),18,20-trien-17-one

7,11-dibromo-12,21-dihydroxy-8,12-dimethyl-4-methylidene-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),18,20-trien-17-one

C27H36Br2O4 (582.098)


   

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy})chromen-4-one

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy})chromen-4-one

C25H26O16 (582.1221)


   

(3r,7s,8s,11r,12s,15s)-7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),4,18,20-tetraen-17-one

(3r,7s,8s,11r,12s,15s)-7,11-dibromo-12,21-dihydroxy-4,8,12-trimethyl-15-(prop-1-en-2-yl)-16-oxatricyclo[16.3.1.0³,⁸]docosa-1(22),4,18,20-tetraen-17-one

C27H36Br2O4 (582.098)


   

(1s,14s,15s,18r,19r)-14,18-dibromo-7-hydroxy-11,15,19,21,21-pentamethyl-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24),10-tetraen-3-one

(1s,14s,15s,18r,19r)-14,18-dibromo-7-hydroxy-11,15,19,21,21-pentamethyl-2,20-dioxatetracyclo[17.2.2.1⁴,⁸.0¹⁰,¹⁵]tetracosa-4,6,8(24),10-tetraen-3-one

C27H36Br2O4 (582.098)


   

10-chloro-7-(3-chloro-2,4-dimethoxy-6-methylphenyl)-2,4-dihydroxy-9-methoxy-12,12-dimethyltetracene-5,6,11-trione

10-chloro-7-(3-chloro-2,4-dimethoxy-6-methylphenyl)-2,4-dihydroxy-9-methoxy-12,12-dimethyltetracene-5,6,11-trione

C30H24Cl2O8 (582.0848)


   

7-bromo-16-(2-bromopropan-2-yl)-22-hydroxy-8,13-dimethyl-4-methylidene-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one

7-bromo-16-(2-bromopropan-2-yl)-22-hydroxy-8,13-dimethyl-4-methylidene-12,17-dioxatetracyclo[17.3.1.0³,⁸.0¹¹,¹³]tricosa-1(23),19,21-trien-18-one

C27H36Br2O4 (582.098)